Ultragenyx Pharmaceutical (RARE) EPS (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) EPS from Mar 31, 2013 to Mar 31, 2026. The TTM Ultragenyx Pharmaceutical (RARE) EPS is -$6.28. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Ultragenyx Pharmaceutical (RARE) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +5.98% |
| 3 Years TTM | -15.05% |
| 5 Years TTM | +15.22% |
| 10 Years TTM | +3.14% |
| All Time TTM | +5.90% |
Annual EPS change of Ultragenyx Pharmaceutical (RARE)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.88 | -68.38% |
| 2025 | -$5.95 | -3.23% |
| 2024 | -$6.15 | -16.58% |
| 2023 | -$7.37 | -26.83% |
| 2022 | -$10.08 | +53.92% |
| 2021 | -$6.55 | +134.48% |
| 2020 | -$2.79 | -59.90% |
| 2019 | -$6.96 | +79.21% |
| 2018 | -$3.89 | -43.20% |
| 2017 | -$6.84 | +14.74% |
| 2016 | -$5.96 | +59.19% |
| 2015 | -$3.75 | +100.00% |
| 2014 | -$1.87 | -36.97% |
| 2013 | -$2.97 | +77.84% |
| 2012 | -$1.67 | N/A |
Comparison Ultragenyx Pharmaceutical (RARE) five years EPS CAGR with competitors
Ultragenyx Pharmaceutical (RARE) five years EPS CAGR is 15.22%.